Erectile Dysfunction in Hypertensive Subjects
- 1 November 1996
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 28 (5) , 859-862
- https://doi.org/10.1161/01.hyp.28.5.859
Abstract
Hypertension is often cited as a risk factor for erectile dysfunction. To clarify the relation between hypertension and erectile dysfunction, we evaluated 32 consecutive hypertensive and 78 normotensive impotent men with respect to multiple potential determinants and parameters of erectile function, including medical and sexual history, depression, hormonal profile, penile nocturnal tumescence, penile vascular supply, and pudendal nerve conduction. The hypertensive men were older, had higher body mass index, and used more medications than the normotensive men. The groups were not different with respect to the prevalence of smoking and peripheral vascular disease, but the hypertensive men had a marginally higher rate of ischemic heart disease ( P =.06). The prevalence of depression, abnormal nocturnal penile tumescence, anomalous pudendal nerve conduction, and impairment in arterial supply as determined by penile brachial index were similar in the two groups. Testosterone and bioavailable testosterone levels were lower in the hypertensive men. After stratification by age and body mass index, hypertensive men younger than 50 years with body mass index less than 30 kg/m 2 had significantly lower testosterone levels (12.0±1.7 versus 21.3±1.4 nmol/L, P <.02) but not bioavailable testosterone levels (3.9±0.7 versus 6.4±0.7 nmol/L, P <.17) than the corresponding normotensive group. Prolactin, follicle-stimulating hormone, and luteinizing hormone levels of the two groups were not significantly different. Contrary to common belief and with the exception of lower circulating testosterone levels, the overall analysis showed little difference between hypertensive and normotensive men with respect to a wide range of classic determinants of erectile function. Direct study of the local vascular erectile apparatus appears necessary for further elucidation of the mechanisms underlying erectile dysfunction in hypertensive men.Keywords
This publication has 14 references indexed in Scilit:
- Assessment of 5α‐reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretionClinical Endocrinology, 1994
- Cigarette smoking and othervascular risk factors in vasculogenic impotenceUrology, 1991
- C19and C215β/5αMetabolite Ratios in Subjects Treated with the 5α-Reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency*Journal of Clinical Endocrinology & Metabolism, 1990
- Erectile dysfunction in diabetes and hypertensionUrology, 1985
- Leydig Cell Function in Normal Men: Effect of Age, Life-Style, Residence, Diet, and Activity*Journal of Clinical Endocrinology & Metabolism, 1984
- Evoked Responses from the Pudendal NerveJournal of Urology, 1982
- Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension.Hypertension, 1982
- Suppressive Effect of 1,25-Dihydroxyvitamin D3on Circulating Parathyroid Hormone in Acute Renal FailureJournal of Clinical Endocrinology & Metabolism, 1981
- Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptivesContraception, 1974
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961